Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance, PA #01066. 

---
identifier: "/us/fr/01-18970"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance, PA #01066."
title_number: 0
title_name: "Federal Register"
section_number: "01-18970"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance, PA #01066."
positive_law: false
currency: "2001-07-31"
last_updated: "2001-07-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-18970"
document_type: "notice"
publication_date: "2001-07-31"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "66 FR 39516"
fr_volume: 66
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance, PA #01066.

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance, PA #01066.

*Times and Dates:* 8:30 a.m.-9 a.m., August 16, 2001. (Open) 9 a.m.-5:30 p.m., August 16, 2001. (Closed)

*Place:* Hilton Atlanta Airport, 1031 Virginia Avenue, Atlanta, Georgia 30354.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Deputy Director for Program  Management, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement: PA #01066

*Contact Person for More Information:* Marsha Jones, Health Scientist, Centers for Disease Control and Prevention, National Center for Infectious Diseases, 1600 Clifton Road, m/s C19, Atlanta, GA., 30333. Telephone (404)639-2603, email: *[email protected].*

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: July 25, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).